Large institutional investors pursuing direct deals on a solo basis represents a logical evolution of the private equity industry and shouldn’t necessarily be regarded as a threat, Asia-focused buyout managers told the AVCJ Forum.
“It’s happening in Asia to some extent, although most LPs doing direct deals are co-investing or co-sponsoring,” said Jean-Eric Salata, CEO and founding partner at Baring Private Equity Asia. “I...
Chinese gene therapy specialist Exegenesis Bio has received $20 million in Series B funding led by Legend Capital. It will be used to support clinical development of the company’s drug portfolio.
Alibaba Group has led a $300 million round for Chinese electric vehicle (EV) manufacturer Xpeng Motors. It comes barely two weeks after the company closed an extended Series C round of $500 million.
EDBI, the investment arm of Singapore’s Economic Development Board, has invested in Vesta, a US-based fraud and payment technology start-up with ambitions to expand into Asia.
Hana Financial has invested KRW100 billion ($85 million) in a portfolio of Korean waste to energy (WTE) projects controlled by Global Infrastructure Partners (GIP).